Showing results (1081-1090 of 7,002) with videos related to
Sort By:
Pageof 701
Cancer Science|September 1, 2010
Identification and characterization of cancer stem cells in ovarian yolk sac tumorsShiro Suzuki, Mikio Terauchi, Tomokazu Umezu, et al.Cancer Science|October 1, 2010
Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigenMasasuke Ohno, Atsushi Natsume, Ken Ichiro Iwami, et al.Cancer Science|October 1, 2010
Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancerYoshinori Ito, Koichi Nagasaki, Yoshio Miki, et al.Cancer Science|September 30, 2010
Mechanisms of dNTP supply that play an essential role in maintaining genome integrity in eukaryotic cellsHiroyuki Niida, Midori Shimada, Hiroshi Murakami, et al.Cancer Science|September 30, 2010
Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibilitySuyoun Chung, Hidewaki Nakagawa, Motohide Uemura, et al.Cancer Science|September 4, 2010
Poly (γ, L-glutamic acid)-cisplatin bioconjugate exhibits potent antitumor activity with low toxicity: a comparative study with clinically used platinum derivativesZhen Feng, Yuping Lai, Haifeng Ye, et al.Cancer Science|July 9, 2010
Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: potential role in tumor progressionKosuke Miyai, Sohei Yamamoto, Tomohiko Asano, et al.Cancer Science|July 9, 2010
Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cellsEun-Yeung Gong, Eunsook Park, Keesook LeeCancer Science|July 9, 2010
Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancerRabindra N Bhattacharjee, Alexander V Timoshenko, Jing Cai, et al.Cancer Science|July 9, 2010
Enhanced antitumor efficacy of folate-linked liposomal doxorubicin with TGF-β type I receptor inhibitorYukimi Taniguchi, Kumi Kawano, Takuya Minowa, et al.Pageof 701